Advertisement

Topics

Cigna Corporation and AstraZeneca Company Profile

18:01 EDT 23rd June 2018 | BioPortfolio


News Articles [821 Associated News Articles listed on BioPortfolio]

Cigna Launches “Answers by Cigna” on Amazon Alexa

Today, Cigna announced it will be the first global health service company to offer a skill aimed at personalizing and simplifying health benefits information with the launch of “Answers by Cigna,”...

Cigna to answer more than 150 benefits-related questions via Amazon Alexa

Cigna has

Health Insurer Cigna to Acquire Express Scripts for $67 Billion: 5 Things to Know

Cigna Corporation has acquired Express Scripts Holding Company in a cash and stock transaction valued at approximately $67 billion, including Cigna’s assumption of approximately $15 billion in E...

Cigna Declares Annual Dividend

The board of directors of Cigna Corporation (NYSE: CI) today declared a cash dividend of $0.04 per share of Cigna common stock, payable on April 10, 2018 to shareholders of record...

Cigna acquires Express Scripts, AMA expresses concern

Cigna Corporation and Express Scripts Holding Company announced a definitive agreement in which Cigna will acquire Express Scripts for approximately $67 billion, according to a press release.“We are...

Cigna Finds More Evidence Of Loneliness In America

This is what a recent survey conducted by Cigna and Ipsos of over 20,000 Americans ages 18 years and older revealed.

With Express Scripts Debt, Cigna Needs Anthem Break-Up Money

Since last year, Cigna is seeking $13 billion in damages and a $1.85 billion breakup fee from Anthem. A legal win for Cigna could help pay down the large debt load from the insurer's acquisition of Ex...

Cigna and Express Scripts Announce Acquisition Agreement

Cigna Corporation and Express Scripts have announced an agreement in which Cigna will purchase the pharmacy benefit manager (PBM) for $67 billion, which includes $15 billion in Express Scripts debt.&n...

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Medical Science Liaisons in Real-World Evidence Studies: Experience of AstraZeneca Russia.

There is no doubt that real-world evidence studies have the potential to improve and accelerate the development and delivery of safe and cost-effective innovative medicines to patients as well as infl...

Applying American Society of Addiction Medicine Performance Measures in Commercial Health Insurance and Services Data.

ASAM's Standards of Care for the Addiction Specialist established appropriate care for the treatment of substance use disorders. ASAM identified three high priority performance measures for specificat...

LC-MS/MS reveals the formation of reactive ortho-quinone and iminium intermediates in saracatinib metabolism: Phase I metabolic profiling.

Saracatinib (AZD-0530) is a drug under clinical trials that developed by AstraZeneca. It is considered a dual kinase inhibitor, with selective actions as a Src inhibitor and a Bcr-Abl tyrosine-kinase ...

Secondary patents in the pharmaceutical industry: Missing the wood for the trees?

Introduction The critics of the Innovator pharmaceutical industry allege that secondary patents are trivial modifications over the primary patent, which extend its term and delay the entry of the gene...

Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.

Assessing the rate of drug delivery to the central nervous system (CNS) in vitro has been used for decades to predict whether CNS drug candidates are likely to attain their pharmacological targets, lo...

Clinical Trials [40 Associated Clinical Trials listed on BioPortfolio]

Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis

This study is to evaluate non inferiority of Eurofarma budesonide nasal spary x referral Astrazeneca budesonide. Half patients will receive Eurofarma medication and half patients will rece...

Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions

Subjects to compare the single dose bioavailability of Torrent's Esomeprazole Magnesium DR Capsules 40 mg and Nexium® 40 mg DR Capsules of AstraZeneca LP, USA. Dosing periods of studies w...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis

This study is to evaluate non inferiority of Eurofarma budesonide nasal spray x referral Astrazeneca budesonide. Half patients will receive Eurofarma medication and half patients will rece...

Companies [361 Associated Companies listed on BioPortfolio]

Cigna Corporation and AstraZeneca

Cigna Corporation and The Cigna Foundation

The Cigna Foundation is a private foundation funded by contributions from Cigna Corporation (NYSE: CI) and its subsidiaries. The Cigna Foundation supports organizations sharing it...

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a leader in gastrointestin...

AstraZeneca Pharmaceuticals LP

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a lead...

CIGNA HealthCare

CIGNA (NYSE:CI), a global health service company, is dedicated to helping people improve their health, well-being and sense of security. CIGNA Corporation's operating subsidiaries...

More Information about "Cigna Corporation and AstraZeneca" on BioPortfolio

We have published hundreds of Cigna Corporation and AstraZeneca news stories on BioPortfolio along with dozens of Cigna Corporation and AstraZeneca Clinical Trials and PubMed Articles about Cigna Corporation and AstraZeneca for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cigna Corporation and AstraZeneca Companies in our database. You can also find out about relevant Cigna Corporation and AstraZeneca Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record